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Serotonin (5HT) is a constituent of the so-called “inﬂammatory soup” that sensitizes nociceptors during
inﬂammation. Nevertheless, receptors and signaling mechanisms that mediate an excitation of dorsal
root ganglion (DRG) neurons by 5HT remained controversial. Therefore, capsaicin-sensitive nociceptive
neurons dissociated from rat DRGs were used to investigate effects of 5HT on membrane excitability and
currents through ligand- as well as voltage-gated ion channels. In 58% of the neurons tested, 5HT
increased action potential ﬁring, an effect that was abolished by the 5HT2 receptor antagonist ritanserin,
but not by the 5HT3 antagonist tropisetron. Unlike other algogenic mediators, such as PGE2 and bra-
dykinin, 5HT did not affect currents through TTX-resistant Naþ channels or Kv7 Kþ channels. In all
neurons investigated, 5HT potentiated capsaicin-evoked currents through TRPV1 channels, an effect that
was attenuated by antagonists at 5HT2A (4 F 4 PP), 5HT2B (SB 204741), as well as 5HT2C (RS 102221)
receptors. 5HT triggered slowly arising inward Cl currents in 53% of the neurons. This effect was
antagonized by the 5HT2C receptor blocker only, and the current was prevented by an inhibitor of Ca2þ-
activated chloride channels (CaCC). The 5HT-induced increase in action potential ﬁring was also abol-
ished by this CaCC blocker and by the TRPV1 inhibitor capsazepine. Amongst the subtype selective 5HT2
antagonists, only RS 102221 (5HT2C-selectively) counteracted the rise in action potential ﬁring elicited
by 5HT. These results show that 5HT excites DRG neurons mainly via 5HT2C receptors which concom-
itantly mediate a sensitization of TRPV1 channels and an opening of CaCCs.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Nociceptive dorsal root ganglion (DRG) neurons are excited by
noxious stimuli such as heat, cold, excessive pressure, or chemical
irritation, but not by nonhazardous stimuli such as warming or
light touch which, however, sufﬁce to trigger ﬁring in non-henylbutyl) piperidine; CaCC,
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Ltd. This is an open access article unociceptive DRG neurons (Julius and Basbaum, 2001). Under con-
ditions of tissue damage and inﬂammation, nociceptors get sensi-
tized towards such non-noxious stimuli by a plethora of signaling
molecules that are released from surrounding cells. These media-
tors are collectively characterized as “inﬂammatory soup”
(Basbaum et al., 2009) and contain protons, kinins, prostanoids,
nucleotides, histamine, and serotonin/5HT (Dray, 1995).
The role of serotonin in pain sensation is particularly complex,
as this monoamine is known to exert pro- as well as antinociceptive
effects in the central as well as peripheral nervous system. Even at
the level of DRG neurons, serotonin has been found to either boost
or mitigate nociceptive signaling (Sommer, 2004). This diversiﬁ-
cation of serotonin actions in DRG neurons is related to the large
number of different 5HT receptors that are available for the
monoamine to elicit its effects. This receptor family comprises
seven subclasses, 5HT1 to 5HT7, and each of these groups can
harbor one (5HT4, -6, -7) to ﬁve (5HT1) different proteins (Hoyer
et al., 2002). With the exception of 5HT3, which belongs to the
cys-loop family of ligand-gated ion channels, all these receptors
display a 7 transmembrane segment topology and signal viander the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Gi/o, 5HT2 to Gq/11, and the remaining ones mainly to Gs (Hannon
and Hoyer, 2008). In fact, 5HT1A, 5HTIB, 5HT1D, 5HT1E, 5HT1F,
5HT2A, 5HT2B, 5HT2C, 5HT3A, 5HT3B, 5HT4, 5HT5A, 5HT5B, 5HT6,
and 5HT7 receptors have been reported to be expressed in DRGs
(Nicholson et al., 2003; Pierce et al., 1996).
Incipiently, 5HT released from platelets and mast cells during
tissue damage and inﬂammationwas believed to excite nociceptors
via 5HT3 receptors (Julius and Basbaum, 2001), but then it turned
out that this ionotropic receptor was only relevant in a minor
subset of DRG neurons and only for delayed nociceptive responses
(Zeitz et al., 2002). Therefore, 5HT must be expected to act on DRG
neurons rather via G protein-coupled receptors (GPCRs) as do
bradykinin (Liu et al., 2010), prostaglandin E2 (England et al., 1996)
and nucleotides (Yousuf et al., 2011). The excitatory actions of such
algogenic mediators on DRG neurons in vitro parallel their proal-
getic effects in vivo (Liu et al., 2010). Vice versa, a decrease in the
excitability of DRG neurons due to ion channel modulation in vitro
is correlated with analgesia in vivo (Du et al., 2014). Excitation of
sensory neurons by the aforementioned inﬂammatory mediators
via GPCRs involves changes in the gating of various ion channels:
activation of bradykinin B2 receptors facilitates the opening of
TRPV1 channels and TMEM16A Ca2þ-activated Cl channels
(CaCCs) and simultaneously inhibits Kv7 Kþ channels (Brown and
Passmore, 2010; Liu et al., 2010); prostaglandin E2 enhances cur-
rents through tetrodotoxin (TTX) resistant Naþ channels via EP2 as
well as EP4 receptors (Matsumoto et al., 2005) and currents
through TRPV1 channels via EP1 receptors (Moriyama et al., 2005);
nucleotides promote the gating of TRPV1 channels and impede the
gating of Kv7 Kþ channels, both via P2Y1 as well as P2Y2 receptors
(Yousuf et al., 2011). In comparison, in DRG neurons 5HT has been
proposed to potentiate TRPV1 channels via 5HT2, 5HT4, and/or
5HT7 receptors (Ohta et al., 2006; Sugiuar et al., 2004) and TTX
resistant Naþ channels via 5HT4 receptors (Cardenas et al., 1997).
Although 5HT is also known to increase the excitability of DRG
neurons, receptor subtypes and mechanisms involved therein have
not been elucidated (Cardenas et al., 2001). In particular, it
remained unclear whether ion channels other than TRPV1 and TTX
resistant Naþ channelsmight be relevant for the control of neuronal
excitability in DRGs by 5HT and which of the three distinct 5HT2
receptor subtypes were involved. These issues are addressed below,
and the results reveal a previously unrecognized role of 5HT2C
receptors linked to Ca2þ-activated Cl channels.2. Materials and methods
2.1. Materials
5-Hydroxytryptamine (serotonin, 5HT), gamma-aminobutyric
acid (GABA), capsaicin, ritanserin, tropisetron hydrochloride along
with bulk chemicals were obtained from Sigma-Aldrich (Vienna,
Austria). Bradykinin, 6-(1,1-Dimethylethyl)-2-[(2-furanylcarbonyl)
amino]-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid
(CaCC Inh. - A01), SB 204741 (N-(1-Methyl-1H-5-indolyl)-N0-(3-
methyl-5-isothiazolyl)urea), thapsigargin, and XE991 (10,10-bis(4-
pyridinylmethyl)-9(10H)-anthracenone) were purchased from
Tocris (Bristol, UK). 4-(4-ﬂuorobenzoyl)-1-(4phenylbutyl) piperi-
dine (4 F 4 PP) oxalatewas obtained from Santa Cruz Biotechnology,
Inc. (Heidelberg, Germany), capsazepine from Sanova Pharma Ges.
m. b. H. (Vienna, Austria), 8-[5-(2,4-dimethoxy-5-(4-
triﬂuoromethylphenylsulphonamido) phenyl-5-oxopentyl]-1,3,8-
triazaspiro[4,5]decane-2,4-dione (RS102221) from Szabo-Scandic
(Vienna, Austria), and tetrodotoxin (TTX) from Latoxan (Valence,
France).2.2. Primary cultures of DRG neurons
Our methods of DRG culture preparation have been described in
detail before (Klinger et al., 2012). Rats were sacriﬁced by decapi-
tation after short CO2 asphyxia in accordance with the ARRIVE
guidelines and the Austrian animal protection law (see http://
www.ris.bka.gv.at/Dokumente/BgblAuth/BGBLA_2012_I_114/
BGBLA_2012_I_114.pdf) and the Austrian animal experiment by-
laws (see http://www.ris.bka.gv.at/Dokumente/BgblAuth/BGBLA_
2012_II_522/BGBLA_2012_II_522.pdf) which implement European
(DIRECTIVE 2010/63/EU; see http://eur-lex.europa.eu/LexUriServ/
LexUriServ.do?uri¼OJ:L:2010:276:0033:0079:en:PDF) in Austrian
law. Collected ganglia from all levels were incubated in collagenase
(1.5 mg ml1, Sigma-Aldrich) and dispase (3.0 mg ml1, Boehringer
Mannheim, Vienna, Austria) for 30 min followed by 0.25% trypsin
(Worthington, Lakewood, NJ, USA) for 15 min at 37 C. After tritu-
ration, cells were resuspended in Dulbecco's Modiﬁed Eagle Me-
dium containing 4.5 g l1 glucose, 10 mg l1 insulin, 25 000 IU l1
penicillin, 25 mg l1 streptomycin (all Sigma-Aldrich), 50 mg l1
nerve growth factor (Biomedica, Vienna, Austria), and 5% heat-
inactivated fetal calf serum (Biochrom, Berlin, Germany) and
seeded onto 35 mm culture dishes coated with poly D-lysine
(Sigma-Aldrich). Cultures were kept at 37 C in a humidiﬁed 5% CO2
atmosphere. On days 1 and 3 after preparation, the medium was
exchanged entirely.
2.3. Electrophysiology
Electrophysiological experiments were carried out as described
recently (Klinger et al., 2015) using small diameter DRG neurons.
Unless stated otherwise, each of the neurons included in the
analysis showed capsaicin-induced currents (Icaps) as an indication
of nociceptive functions. Recordings were performed at room
temperature (20 - 24 C) using an Axopatch 200B ampliﬁer, the
pCLAMP 10.4 hard- and software and digitizedwith a Digidata 1440
(Molecular Devices, Sunnyvale, California). All current clamp re-
cordings as well as voltage-clamp recordings of currents through
ligand-gated ion channels (P2X, 5HT3), TRPV1 and Kv7 voltage-
gated potassium channels were conducted in the perforated
patch-clamp mode, whereas currents through TTX-resistant
voltage-gated sodium channels were recorded in conventional
whole-cell mode. Traces of voltage-gated sodium currents were
low-pass ﬁltered at 10 kHz and digitized at 50 kHz. All other re-
cordings were low-pass ﬁltered at 2 kHz and digitized at 10 kHz.
Data were analyzed ofﬂine using the Clampﬁt 10.4 software (Mo-
lecular Devices). Patch-pipettes were pulled from borosilicate glass
capillaries (GB150-8P, Science Products) with a Sutter P-97 puller
(Sutter Instruments, Novato, CA, USA) using a trough ﬁlament
(FT330B, Science Products, Hofheim, Germany). For perforated-
patch recordings, the pipette resistances were between 1 and
3.5 MU. Pipettes were front-ﬁlled with internal solution and then
backﬁlled with the same solution containing 500 mg ml1 ampho-
tericin B. When the series resistance had dropped below 20 MU
after 20e30 min, recordings were started. For conventional whole-
cell recordings, tip resistances were between 2.5 and 3.5 MU. After
achieving a GU seal, cell membranes were ruptured by applying
negative pressure to reach series resistances of 3e7 MU. Cells were
allowed to equilibrate for 2 min before the start of recordings.
The internal solution for recordings of membrane excitability
and currents through TRPV1 channels, 5HT3 receptors, P2X re-
ceptors as well as Kv7 channels contained (mM): K2SO4 (75), KCl
(55), MgCl2 x 6H2O (8.0), and HEPES (10) andwas adjusted to pH 7.4
with KOH. In recordings of currents through calcium-activated
chloride channels, a pipette solution previously optimized for this
purpose (Salzer et al., 2014) was used instead and consisted of
I. Salzer et al. / Neuropharmacology 110 (2016) 277e286 279(mM): KCl (140), CaCl2 x 2H2O (1.0), MgCl2 (0.7), EGTA (10), HEPES
(10), and KOH (29.4), thereby achieving pH 7.4. In experiments
focusing on the reversal potential of Cl currents, the intracellular
solution had to contain Kþ channel blockers and therefore
comprised (mM) CsCl (140), TEA-Cl (20), CaCl2 x 2H2O (1.0), EGTA
(5), Glucose (10), HEPES (10), and CsOH (15), thereby achieving pH
7.4. For recordings of TTX-resistant voltage-gated sodium currents,
the internal solution was composed as follows (mM): Cs aspartate
(145), NaCl (10), HEPES (10), EGTA (1.0), MgCl2 (2.0) Na-ATP (1.0),
Na-GTP (0.3) adjusted to pH 7.4 with CsOH. The bath solution for all
perforated-patch recordings contained (mM): NaCl (140), Glucose
(20), HEPES (10), CaCl2 x 2H2O (2.5), MgCl2 (2.0), KOH (3.0), and
NaOH (2.0) to achieve pH 7.4. In whole-cell recordings of Naþ cur-
rents, the composition was the following (mM): TEA-Cl (125), NaCl
(15), Glucose (11), HEPES (5.0), CsCl (3.0), MgCl2 (1.0), and TTX
(0.0005), adjusted to pH 7.4 with TEA-OH. The pipette solution
containing KCl did not result in a liquid junction potential. The
pipette solution containing K2SO4 resulted in a junction potential
of 7.4 mV, the combination of solutions for recordings of voltage-
gated sodium currents led to junction potentials of20 mV, both of
which were corrected for during experimentation. Stock solutions
of 4 F 4 PP, BAPTA-AM, CaCC-Inh. A01, capsazepine, GF 109203X, RS
102221, SB 204741, ritanserin, thapsigargin, tropisetron, and
U73122 were prepared in DMSO, stock solutions of capsaicin were
prepared in ethanol and were then diluted in external solutions. In
control recordings, DMSO was used as solvent in appropriate con-
centrations. Drugs were either applied with a DAD-12 drug appli-
cation device (ALA Scientiﬁc Instruments Inc., Westbury, NY) or an
OctaFlow perfusion system (ALA Scientiﬁc Instruments Inc.), which
both permit complete exchange of solutions surrounding the
patched cell within 100 ms.
To test the effect of 5HT on membrane excitability, small
diameter neurons were injected with 5 evenly increasing current
steps (0.1e0.3 nA). Changes in excitability were evaluated by the
number of evoked action potentials in presence of 5HTas compared
to those in its absence. Blockers of ion channels or receptor an-
tagonists were present for 60 s before application of 5HT.
Currents through 5HT3, P2X and TRPV1 channels were recorded
at a steady holding voltage of 70 mV. ATP and 5HT were applied
for 2 s, respectively. For recordings of currents through TRPV1
channels (ICaps), capsaicin (0.3 mM) was applied for 15 s once every
2min 5HTwas present for 30 s before application of capsaicin. Peak
current amplitudes were analyzed. Currents through Kv7 channels
were evoked by clamping cells to30mV followed by a 1 s step to -
55 mV once every 15 s to deactivate Kv7 channels. The deactivation
amplitude between 20 ms after the start and 20 ms before the end
of the hyperpolarizing voltage step was evaluated as the amplitude
of currents through Kv7 channels (Klinger et al., 2012). For re-
cordings of currents through calcium-activated chloride channels,
cells were clamped to 65 mV (which approximately equals the
resting membrane potentials; see 3.1), and 5HT was applied twice
for 120 s with a 6 min washout period between the applications
(Salzer et al., 2014). Antagonists of GPCRs and calcium-activated
chloride channels were present for 60 s prior to and throughout
the application of 5HT and during the 5 min washout phase after
the application. An average of mean current levels during 10 s pe-
riods before the application of 5HT and 10 s periods at the end of
the 5 min washout phase were taken as baseline and compared to
the mean current levels during the last 10 s period of the 5HT
application. Voltage-activated Naþ currents were activated
routinely by 15 ms voltage steps from 90 mV to 10 mV once
every 5 s. For current voltage relations of Naþ channels, DRG neu-
rons were depolarized for 10 ms from a holding potential
of 90 mV to voltages between 60 mV and þ20 mV. In between
the voltage steps, cells were clamped to 80 mV and a P/6 protocolwas used for leak subtraction. Voltage-gated sodium channels were
exclusively examined on freshly dissociated neurons; all other re-
cordings were performed on days 1e5 after dissociation.
2.4. Statistics
All data are represented as arithmetic means ± SEM; n values
give the number of single cells measured. The statistical tests used
are indicated in the text and the ﬁgure legends, respectively.
3. Results
3.1. Serotonin increases the excitability of DRG neurons via 5HT2
receptors
To analyze effects of 5HT on the excitability of DRG neurons,
current clamp experiments were performed, and currents of evenly
increasing amplitudes were injected in order to elicit action po-
tential ﬁring. Via this procedure, excitability enhancing effects of
bradykinin (Liu et al., 2010), prostaglandin E2 (England et al., 1996),
and nucleotides (Yousuf et al., 2011) have been demonstrated for
DRG neurons. In the perforated patch conﬁguration, the resting
membrane potential of DRG neurons amounted to 65.2 ± 0.5 mV
(n ¼ 131), and injection of a sequence of 5 depolarizing currents
with amplitudes increasing from 0.1 to 0.3 nA led to the ﬁring of
5.4 ± 0.4 action potentials (n ¼ 131). In an initial set of 64 neurons,
37 displayed increased excitability in the presence of 10 mM 5HT:
the number of action potentials ﬁred in the absence of 5HT was
6.3 ± 0.7, and this value rose to 25.8 ± 3.4 in the presence of the
monoamine (see Fig. 1a for a representative recording). In these 37
neurons, 5HT also caused a depolarization of the membrane po-
tential by 3.7 ± 0.6 mV. In the remaining 27 neurons, the number of
action potentials ﬁred in the absence (3.5 ± 0.4) and presence of
5HT (4.4 ± 0.4) was comparable and the membrane potential
remained apparently unaffected.
To reveal which receptors might be involved in the excitatory
actions described above, 5HT was applied again in the presence of
30 nM tropisetron to 7 of the responsive neurons; this concentra-
tion is sufﬁcient to abolish the effects of 10 mM serotonin at
neuronal 5HT3 receptors (Dorostkar and Boehm, 2007). However,
the effects of 5HT were not altered by this 5HT3 antagonist (Fig. 1a
and b). Therefore, 1 mM of the 5HT2 receptor antagonist ritanserin
(Knight et al., 2004) was applied after removal of tropisetron and
turned out to abrogate the actions of the agonist (Fig. 1a and b).
Thus, the 5HT-dependent increase in the excitability of DRG neu-
rons did not involve 5HT3 receptors, but was rather mediated by
5HT2 receptors.
To reveal whether DRG neurons do express functionally signif-
icant levels of 5HT3 receptors, voltage clamp experiments were
performed to search for 5HT-induced currents. However, at con-
centrations up to 100 mM the monoamine failed to induce signiﬁ-
cant inward currents at negative membrane potentials (Fig. 1c and
d). For comparison, in the very same neurons 10 mM ATP caused
inward currents with amplitudes of several hundred pA (Fig. 1c and
d) as described before (Yousuf et al., 2011). Hence, from the data
obtained in current as well as voltage clamp experiments one may
conclude that 5HT3 receptors cannot be of major importance.
3.2. Serotonin sensitizes TRPV1 channels via three 5HT2 receptor
subtypes
In DRG neurons dissected from either rats (Ohta et al., 2006) or
mice (Sugiuar et al., 2004), 5HT has been found to sensitize TRPV1
channels. This mechanism is also known to contribute to the raised
excitability of DRG neurons in the presence of bradykinin,
Fig. 1. Increase in membrane excitability of rat DRG neurons caused by 5HT. Action potentials were recorded in perforated current clamp mode (a and b) and were triggered by
injecting ﬁve increasing current steps (shown in a, left panel). Application of 5HT, tropisetron and ritanserin was started 60 s before current injection. In perforated voltage clamp
mode (c and d), currents through 5HT3 and P2X receptors were induced by 2 s applications of the indicated concentrations of 5HT and ATP, respectively, both at a voltage of 70 mV.
a. Representative voltage traces recorded before (control) or during application of 10 mM 5HT, either alone or in the presence of 30 nM tropisetron (5HT þ tropisetron) or 1 mM
ritanserin (5HT þ ritanserin). b. Total number of action potentials triggered by the 5 increasing current injections in presence of 5HT either alone or together with ritanserin and
tropisetron, respectively (n ¼ 5). * indicates signiﬁcant difference vs. 5HT at p < 0.05 (Kruskal-Wallis test, Dunn's multiple comparison). c. Representative traces of currents evoked
by application of the indicated concentrations of either 5HT or ATP. d. Peak amplitudes of currents evoked by application of the indicated concentrations of 5HT and ATP, respectively
(n ¼ 9). **, *** indicate signiﬁcant differences vs. ATP at p < 0.01 and p < 0.001, respectively (Kruskal-Wallis test, Dunn's multiple comparison).
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reveal whether such an action could also contribute to the 5HT2
receptor-mediated increase in DRG excitability described above,
currents through TRPV1 channels were elicited by 0.3 mM capsaicin
in the absence and presence of 10 mM 5HT. The monoamine
potentiated capsaicin-induced currents in all neurons (n ¼ 28)
investigated, but the effect varied considerably between single cells
(Fig. 2b to d). Nevertheless, in all subsets of neurons (Fig. 2b to d),
the 5HT dependent increase in current amplitudes was statistically
signiﬁcant (p < 0.05, Friedman test followed by Dunn's post-hoc
comparison). As observed with the 5HT-induced increase in excit-
ability, the effect of 5HT on TRPV1 currents was signiﬁcantly
attenuated by 1 mM ritanserin (Fig. 2a and b). Moreover, in the
presence of 1 mM ritanserin, 10 mM 5HT failed to signiﬁcantly
augment capsaicin-induced currents (n ¼ 12; p > 0.05, Friedman
test followed by Dunn's post-hoc comparison).
As evidence for the expression of each of the three 5HT2 re-
ceptor subtypes (5HT2A, 5HT2B, 5HT2C) in DRGs has been pre-
sented (see Introduction), the subtype-selective antagonists RS
102221, 4 F 4 PP (Acu~na-Castillo et al., 2002), and SB 204741 (Forbes
et al., 1995) were used to reveal which of these subtypes contribute
to the potentiation of TRPV1 channels by 5HT. Each of these agents
attenuated the potentiation of capsaicin-evoked currents by 10 mM
5HT (Fig. 2 c to d), and in the presence of 100 nM4 F 4 PP, 200 nM SB
204741, and 30 nM RS 102221, respectively, this 5HT concentration
failed to cause signiﬁcant changes in TRPV1 current amplitudes
(n ¼ 5 to 6 in each case; p > 0.05, Friedman test followed by Dunn's
post-hoc comparison). Thus, all three 5HT2 receptor subtypes can
contribute to the potentiation of TRPV1 channels by 5HT.3.3. Serotonin does not affect Kv7 Kþ or TTX-resistant
Na þ channels
Algogenic mediators other than 5HT, such as bradykinin andnucleotides, are known to excite DRG neurons through an inhibi-
tion of voltage-gated Kv7 Kþ channels (see Introduction). However,
currents carried by Kv7 channels, also known as M currents (IM;
Brown and Passmore, 2010) were not altered in the presence of up
to 100 mM 5HT, but reduced in amplitude by >90% when 10 mM
XE991, a speciﬁc M current blocker, was applied (Fig. 3a and b). In
contrast to 5HT, bradykinin, at a concentration of 1 mM, reduced M
current amplitudes by 30% (Fig. 3c).
Another type of voltage-gated ion channel that is known to be
modulated by inﬂammatory mediators such as prostaglandins (see
Introduction) is TTX-resistant Naþ channels. To learn whether the
gating of such channels might be sensitive towards 5HT, current
voltage curves were obtained in the presence of either of 0.5 mM
TTX alone or TTX plus 10 mM 5HT, but no signiﬁcant differences
were to be seen (Fig. 3d to f). In subsequent experiments, Naþ
currents were elicited by depolarizations to 10 mV, and either
10 mM 5HT or 3 mM PGE2 were added to 0.5 mM TTX. Again, current
amplitudes remained unaltered in the presence of 5HT, but were
enhanced by PGE2 (Fig. 3g to i).3.4. Serotonin leads to the gating of Ca2þ activated Cl channels
In addition to Kv7 Kþ and TTX-resistant Naþ channels, CaCCs
have been reported to be involved in the excitation of DRG neurons
via GPCRs (see Introduction). At a holding potential close to the
resting membrane potential (65 mV), the application of 10 mM
5HT led to an inward current that developed with a considerable
delay (Fig. 4a). Such inward currents were observed in 25 out of
47 cells tested. On average, the beginning of the downward
deﬂection of the current trace was found at 20.5 ± 2.2 s after the
start of 5HT application, and the maximum current amplitude was
reached after 99.5 ± 3.8 s (n ¼ 25). To verify that this slow inward
current was mediated by CaCCs, the speciﬁc blocker CaCC Inh. - A01
(Namkung et al., 2011) was used. In the presence of solvent (DMSO),
Fig. 2. Potentiation of currents through TRPV1 channels by 5HT. Currents through TRPV1 channels, recorded in perforated voltage clamp mode at 70 mV, were evoked by
application of capsaicin (0.3 mM) for 15 s in the absence and presence of 5HT2 receptor ligands. a. Representative traces of currents evoked by capsaicin before (ctrl) and during the
presence of either 10 mM 5HT (5HT) or 10 mM 5HT plus 1 mM ritanserin (5HT þ ritanserin). b. Potentiation of capsaicin-evoked currents (Icaps) by 10 mM 5HT applied either alone
(5HT) or together with 1 mM ritanserin (5HT þ ritanserin; n ¼ 12). c. Potentiation of capsaicin-induced currents (Icaps) by 10 mM 5HT applied either alone (5HT) or together with
100 nM 4F4PP (5HT þ 4F4PP; n ¼ 5). d. Potentiation of capsaicin-evoked currents (Icaps) by 10 mM 5HT applied either alone (5HT) or in combination with 200 nM SB204741
(5HT þ SB204741; n ¼ 6). e. Potentiation of capsaicin-induced currents (Icaps) by 10 mM 5HT applied either alone (5HT) or together with 30 nM RS102221 (5HT þ RS102221; n ¼ 5).
p < 0.01 and p < 0.0001 indicate levels of signiﬁcance determined by a Mann-Whitney test for differences between the two bars being compared.
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5HT, and the ratio of the two current amplitudes (I2/I1) was close to
one (Fig. 4a and d) since the two current amplitudes were not
signiﬁcantly different from each other (n ¼ 5; p > 0.05, Mann-
Whitney test). When the second 5HT application was performed
in the presence of 3 mM CaCC-Inh. A01, no obvious inward current
was to be seen; the amplitudes of the second currents were
signiﬁcantly smaller (n ¼ 5; p < 0.05, Mann-Whitney test), and the
I2/I1 ratio dropped below zero (Fig. 4b and d). This proves that the
slowly developing 5HT-induced inward current was mediated by
CaCCs.
To reveal whether this 5HT effect was mediated by 5HT2 re-
ceptors, and if so, by which of the three subtypes, the subtype-
selective 5HT2 receptor antagonists were employed again at the
concentrations mentioned above. These antagonists were tested in
the samemanner as described for the CaCC inhibitor. Of these three
subtype-selective blockers, only RS 102221 signiﬁcantly depressed
the second current as compared to the preceding one (n ¼ 5;
p < 0.05, Mann-Whitney test) and reduced the I2/I1 ratio to a value
below zero (Fig. 4b and d). Thus, 5HT activates CaCCs in DRG neu-
rons via 5HT2C receptors.
To further prove that these currents were carried by Cl ions, the
reversal potential of the currents induced by 5HT was compared to
that of GABA-evoked currents. In both cases, the reversal values lay
between 5 and 10 mV and were not different from each other
(Fig. 4e). Considering that these values were obtained in perforatedpatch recordings, they are in reasonable agreement with the
calculated value of 2 mV. To reveal whether 10 mM 5HT might
affect the Cl equilibrium, GABA-evoked currents were also deter-
mined in the presence of the monoamine, but the resulting reversal
potential was not different from that obtained in its absence
(Fig. 4e). Thus, 5HT did evoke Cl currents, but did not cause sig-
niﬁcant alterations in the Cl equilibrium.
3.5. The excitation of DRG neurons by serotonin involves 5HT2C
receptors as well as TRPV1 and Ca2þ activated Cl channels
Knowing that 5HT acted on TRPV1 as well as Ca2þ activated Cl
channels, the contribution of these two ion channels to the 5HT-
induced increase in excitability was explored. In the presence of
DMSO used as solvent, two consecutive applications of 10 mM 5HT
raised the number of action potentials ﬁred in response to current
injections to a comparable extent (about 400% of control; Fig. 5b);
with both 5HT challenges, the increase in the number of action
potentials was signiﬁcant (n ¼ 9; p < 0.05, Friedman test followed
by Dunn's post-hoc comparison). In the presence of either 10 mM
capsazepine, a TRPV1 antagonist (Dickenson and Dray, 1991), or
3 mM CaCC-Inh. A01, the relative increase in ﬁring rate caused by
5HT was signiﬁcantly diminished (Fig. 5c and d). Moreover, both
channel blockers prevented 5HT from inducing a signiﬁcant rise in
the number of action potentials seen in response to current in-
jections (n ¼ 9 for capsazepine and 8 for CaCC-Inh. A01; p > 0.05,
Fig. 3. Lack of effect of 5HT on currents through Kv7 Kþ and TTX-resistant Naþ channels. Currents through Kv7 channels (IKv7) were recorded in perforated voltage clamp mode.
Cells were clamped to 30 mV and hyperpolarized to 55 mV for 1 s, once every 15 s. Currents through voltage-gated Naþ channels (INa) were recorded in whole-cell voltage clamp
mode in the presence of 0.5 mM tetrodotoxin (TTX). a. Time course of IKv7 in capsaicin positive DRG neurons. 10 mM and 100 mM 5HT were applied as indicated by grey shaded areas,
respectively. XE 991 (10 mM) was applied to conﬁrm the recording of IKv7 (n ¼ 9). b. Representative traces of IKv7 under control conditions (ctrl), during the application of 10 mM 5HT
(5HT), 1 mM bradykinin (Bk) or 10 mM XE991 (XE991). c. Effects of 10 mM 5HT (5HT) and 1 mM bradykinin (Bk) on IKv7 (n ¼ 6). * indicates signiﬁcant difference vs. amplitudes of
control IKv7 (Friedman test, Dunn's post-hoc comparison). d. Naþ currents in a freshly dissociated, capsaicin sensitive DRG neuron evoked by 10 ms depolarizations from 90 mV to
potentials between 60 mV and þ20 mV in the presence of 0.5 mM TTX. e. Naþ currents in the very same neuron evoked again by 10 ms depolarizations from 90 mV to potentials
between 60 mV and þ20 mV, but this time in the presence of 0.5 mM TTX plus 10 mM 5HT. f. Current voltage relations for currents evoked as shown in d and e in 5 different
neurons. For each neuron, all peak current amplitudes were normalized to the peak amplitude obtained at 10 mV (maximum) in the presence of TTX only. Shown are mean values
of normalized current amplitudes (normalized INa). g. Time course of INa evoked by 15 ms depolarizations from 90 mV to 10 mV, applied once every 5 s. 10 mM 5HT and 3 mM
prostaglandin E2 (PGE2) were applied as indicated by the grey shaded areas (n ¼ 7). h. Representative traces of voltage-gated Naþ currents before (TTX) and during application of
10 mM 5HT (5HT) or 3 mM prostaglandin E2 (PGE2). i. Effects of 10 mM 5HT (5HT) and 3 mM prostaglandin E2 (PGE2) on voltage-gated Naþ currents (n ¼ 7). *** indicates a signiﬁcant
difference vs. amplitudes of control INa (Friedman test, Dunn's post-hoc comparison).
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both channels contributed to the excitation of DRG neurons by 5HT.
To unveil which of the three 5HT2 receptor subtypes may
contribute to this excitatory action of 5HT, the subtype-selective
antagonists were assayed in the same way as the two channel
blockers. Only 30 nM RS 102221, but not 4 F 4 PP or SB 204741, was
able to signiﬁcantly reduce the increase in ﬁring rate caused by 5HT
(Fig. 5e to g), and in the presence of the former 10 mM 5HT failed to
signiﬁcantly affect the number of action potentials triggered by the
current injections (n ¼ 9; p > 0.05, Friedman test followed by
Dunn's post-hoc comparison); with the two other 5HT2 receptor
antagonists, 5HT did raise the number of action potentials signiﬁ-
cantly (n¼ 8 for 4 F 4 PP and 9 for SB 204741; p < 0.05 in both cases,Friedman test followed by Dunn's post-hoc comparison). Thus, the
excitation of DRG neurons by 5HT involved 5HT2C, but no other
5HT2 receptor subtype.
4. Discussion
Although it is well established that 5HT does excite peripheral
nociceptors to cause pain, the underlying mechanisms have
remained controversial. Most of the available evidence attributed a
central role to the sensitization of TRPV1 channels, but several
different 5HT receptor subtypes and associated signaling cascades
were suggested to be involved (Loyd et al., 2013). In support of this
general concept, the present results reveal 5HT (i) to potentiate
Fig. 4. Activation of currents through CaCCs channels by 5HT. Cells were recorded in perforated voltage clamp mode at a holding potential of 65 mV (a to d). 5HT was applied
twice for 120 s (indicated by the bar) separated by 300 s washout and 60 s wash-in of the respective modulator. a. Original traces of currents induced by two subsequent ap-
plications of 10 mM 5HT in presence of 0.03% DMSO. b. Original traces of currents induced by two subsequent applications of 10 mM 5HT in the presence of 0.03% DMSO and 3 mM
CaCC-Inh. A01 (as indicated by the grey bar), respectively. c. Original traces of currents induced by two subsequent applications of 10 mM 5HT in the presence of 0.03% DMSO and
30 nM RS102221 (as indicated by the grey bar), respectively. d. Relation of the currents induced by two subsequent applications of 10 mM 5HT (I2/I1) in the presence of 0.03% DMSO
(n ¼ 5), 3 mM CaCC-Inh. A01 (n ¼ 5), 100 nM 4F4PP (n ¼ 5), 200 nM SB204741 (n ¼ 5), and 30 nM RS102221 (n ¼ 5), respectively. ** indicate signiﬁcant differences vs. the I2/I1 ratio
obtained in DMSO at p < 0.01, respectively (Kruskal-Wallis test, followed by Dunn's multiple comparison). e. Currents were evoked by the application of 10 mM 5HT (H), 10 mM GABA
(G), or 10 mM 5HT plus 10 mM GABA (H þ G). During peak current responses, 50 ms ramp depolarizations from 30 mV to þ10 mV were applied in order to determine reversal
potentials, and the resulting current traces are shown. In the inset, the values of reversal potentials obtained with 10 mM 5HT (H), 10 mM GABA (G), or 10 mM 5HT plus 10 mM GABA
(H þ G) in 5 different neurons are indicated. There were no signiﬁcant differences between these three values (p > 0.05; Kruskal-Wallis test, followed by Dunn's multiple
comparison).
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tion potential ﬁring in response to current injections. Such in-
creases as well as decreases in the excitability of DRG neurons
in vitro parallel pro- and analgetic effects in vivo, respectively (Liu
et al., 2010; Du et al., 2014). Here, the causal relation between the
sensitization of TRPV1 channels and the increased excitability of
DRG neurons is also established, as the TRPV1 blocker capsazepine
prevented the escalation of action potential ﬁring by 5HT. Hence,the essential role of TRPV1 sensitization in the excitation of DRG
neurons was documented by these ﬁndings, but the receptor sub-
type involved remained to be determined.
The 5HT-induced rise in neuronal excitability was blocked by
the general 5HT2 receptor antagonist ritanserin, but not by the
5HT3 receptor antagonist tropisetrone, thereby excluding a key role
of ionotropic 5HT receptors. This conﬁrms that 5HT3 receptors
control excitability in only a minor subgroup of DRG neurons (Zeitz
Fig. 5. Roles of ion channels and 5HT2 receptor subtypes in the excitation of DRG neurons by 5HT. Cells were recorded in perforated current-clamp mode. Action potentials
were evoked by ﬁve increasing current injections (shown in a, left panel). The application of 10 mM 5HT was started 45 s before the start of recordings. DMSO 0.03% or antagonists
were present from 60 s onwards prior to the recording. a. Representative traces recorded before (ctrl) or during the application of 10 mM 5HT, either alone (5HT) or in the presence of
30 nM RS102221 (5HT þ RS102221). b-g Increases in the number of action potentials evoked by 5 increasing current injections caused by 10 mM 5HT applied either alone (5HT) or in
the presence of 0.03% DMSO (b, 5HT þ DMSO, n ¼ 9), 10 mM capsazepine (c, 5HT þ capsazepine, n ¼ 8), 3 mM CaCC-Inh. A01 (d, 5HT þ CaCC-Inh, n ¼ 7), 100 nM 4 F 4 PP (e,
5HT þ 4F4PP, n ¼ 8), 200 nM SB204741 (f, 5HT þ SB204741, n ¼ 9), and 30 nM RS102221 (g, 5HT þ RS102221, n ¼ 9), respectively. p < 0.05, p < 0.01 indicate levels of signiﬁcance
determined by a Mann-Whitney test for differences between the two bars being compared.
I. Salzer et al. / Neuropharmacology 110 (2016) 277e286284et al., 2002) members of which must have been either underrep-
resented or even absent from the group of nociceptive neurons
investigated here. Ritanserin also abolished the potentiating effect
of 5HT on TRPV1 currents. This latter 5HT effect was also prevented
by the three subtype-speciﬁc 5HT2 antagonists 4 F 4 PP, SB 204741,
and RS 102221 which display about 100-fold selectivity for 5HT2A,
5HT2B, and 5HT2C, respectively (Acu~na-Castillo et al., 2002; Forbes
et al., 1995). Each of these three subtypes have been found to be
expressed in DRGs (Nicholson et al., 2003; Pierce et al., 1996).
Therefore, one can conclude that all three 5HT2 receptor subtypes
can mediate the sensitization of TRPV1 channels by 5HT.
Nevertheless, only the 5HT2C-selective antagonist interfered
with the 5HT-induced rise in neuronal excitability. From this
apparent discrepancy one can conclude the following: (i) the cho-
sen concentrations of the three antagonists (4 F 4 PP, SB 204741, andRS 102221) acted in a selective manner, as not all 5HT-dependent
responses were affected by each of these three agents. (ii) Addi-
tional, 5HT2C-speciﬁc signaling mechanisms must contribute to
the 5HT-dependent excitation of DRG neurons. (iii) Even though the
5HT-induced increase in action potential ﬁring was prevented by
the TRPV1 blocker capsazepine, a sensitization of TRPV1 channels
alone does not appear to be sufﬁcient for the 5HT-dependent rise in
neuronal excitability. With respect to additional signaling mecha-
nisms that might contribute to the rise in excitability in the pres-
ence of 5HT, the monoamine was tested for effects on currents
through TTX-resistant Naþ channels and Kv7 Kþ channels. Neither
of these two types of channels was affected by 5HT, but they were
enhanced and inhibited by PGE2 and bradykinin, respectively. With
respect to the Naþ channels, a similar pattern of modulation,
potentiation by PGE2, but no effect of 5HT, has been reported for
I. Salzer et al. / Neuropharmacology 110 (2016) 277e286 285mouse DRG neurons before (Rush and Waxman, 2004). In a sub-
population of rat DRG neurons, an enhancement of Naþ currents by
5HT has been described before (Cardenas et al., 1997), but it is not
known whether and to what extent that population might be
present under the culture conditions chosen for the present study.
With respect to Kv7 channels, an inhibition via 5HT2 receptors has
only been described in hypothalamic (Roepke et al., 2012), but not
in DRG neurons.
Another type of ion channel that has recently gained attention
with respect to pain sensation is TMEM16a, also known as anoc-
tamin1, a CaCC (Oh and Jung, 2016). Here, 5HT induced slowly
arising inward directed Cl currents that were abolished in the
presence of CaCC-Inh. A01, an agent that is known to block all
subtypes of CaCCs (Liu et al., 2014). Amongst the three subtype-
speciﬁc 5HT2 antagonists 4 F 4 PP, SB 204741, and RS 102221,
only the latter prevented the gating of CaCCs by 5HT, thereby
indicating that this effect was mediated by 5HT2C receptors. Pre-
viously, activation of B2 bradykinin receptors has been shown to
induce currents through CaCCs in DRG neurons (Liu et al., 2010).
Analogous results have been obtained with these three antagonists
with respect to the increase in action potential ﬁring in the pres-
ence of 5HT. Moreover, this 5HT-dependent excitation of DRG
neurons was also prevented when the Cl channels were blocked
by CaCC-Inh. A01. Together, these data reveal the 5HT2C receptor
mediated activation of CaCCs as decisive step in the excitatory ac-
tion of 5HT on DRG neurons.
The key role of CaCCs in the excitation of DGR neurons by 5HT is
also evidenced by the number of neurons that display speciﬁc re-
sponses towards 5HT. In 100% of the neurons tested, currents
through TRPV1 channels were enhanced by 5HT. However, in just
53% of the neurons did 5HT induce currents through CaCCs, and in
only 58% of the neurons themonoaminewas able to enhance action
potential ﬁring. This further supports the conclusion that the in-
crease in excitability triggered by 5HT was rather related to the
gating of CaCCs than to the sensitization of TRPV1 channels.
In light of the above reasoning, one hast to pose the question as
to why blockade of TRPV1 channels by capsazepine was also suf-
ﬁcient to prevent excitation of DRG neurons by 5HT. TRPV1 and
TMEM16a channels have been found to directly interact with each
other, and blockers of TMEM16a were reported to reduce the
excitatory actions of capsaicin on DRG neurons. The underlying
process is an activation of the CaCC by Ca2þ inﬂux via TRPV1
channels which due to high intracellular Cl concentrations in DRG
neurons leads to depolarization and to a resultant increase in
capsaicin-evoked action potential ﬁring (Deba and Bessac, 2015;
Takayama et al., 2015). This mechanism can also contribute to the
interpretation of the data shown above. Activation of each of the
three 5HT2 receptor subtypes expressed in DRG neurons, 5HT2A,
5HT2B, and 5HT2C, did cause sensitization of TRPV1 channels, but
only activation of 5HT2C receptors led to a concomitant gating of
CaCCs. Obviously, the simultaneous sensitization of TRPV1 and
opening of CaCCs is key to the excitation of DRG neurons by 5HT,
and this is only provided by activation of 5HT2C receptors.
A similar pattern of signaling events in DRG neurons triggered
by an inﬂammatory mediator has been described for bradykinin
(Liu et al., 2010). The prominent role of CaCCs in the sensitization of
DRG neurons by algogenic mediators is further highlighted by the
ﬁnding that the excitatory action of an inﬂammatory soup con-
taining bradykinin, prostaglandin E2, histamine, and 5HT on action
potential ﬁring was largely attenuated or even abolished in neurons
that lacked TMEM16a (Lee et al., 2014). Moreover, inﬂammation-
dependent thermal hyperalgesia and mechanical allodynia were
both found to be reduced in animals that did not express TMEM16a
in DRG neurons (Lee et al., 2014). Thus, activation of CaCCs appears
to be a mechanism that is shared by several constituents of theinﬂammatory soup, and it will be interesting to learnwhether aside
of 5HT and bradykinin other algogenic agents, such as prosta-
glandin E2, histamine, and/or nucleotides, can also act on CaCCs.
DRG neurons, at least during development, express 5HT trans-
porters (Singh et al., 2009). Hence, 5HT might also act via these
transporters. Activation of 5HT transporters heterologously
expressed in muscle cells leads to depolarization and ensuing
gating of voltage activated Ca2þ channels (Ruchala et al., 2014)
which can then result in increases in intracellular Ca2þ. Whether
such a mechanism can also occur in DRG neurons is currently un-
known. Moreover, the fact that the 5HT induced increase in
neuronal excitability was abolished by highly divergent types of
selective blocker (RS 102221, capsazepine, CaCC-Inh. A01) renders a
contribution of 5HT transporters rather unlikely.
In summary, the present results show that 5HT excites DRG
neurons mainly via 5HT2C receptors, the activation of which
simultaneously leads to sensitization of TRPV1 channels and to
opening of CaCCs.
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